Valley Medical Weight Loss, Compounded Semaglutide, Phentermine (Phoenix)

Valley Medical Weight Loss operates multiple locations across Phoenix, AZ, with Dr. Ebrahim Jatta leading a clinical team focused exclusively on medical weight management through pharmacotherapy and metabolic optimization. The practice has built a reputation over several years for delivering structured weight loss programs that combine prescription medications with ongoing clinical monitoring, serving patients throughout the greater Phoenix metropolitan area who seek physician-supervised approaches to obesity and metabolic health.

The clinic's core treatment offerings center on GLP-1 receptor agonist therapy, specifically compounded semaglutide and tirzepatide injections administered under medical supervision. Semaglutide works by mimicking the glucagon-like peptide-1 hormone to regulate appetite and glucose metabolism, while tirzepatide combines GIP and GLP-1 receptor agonism for dual incretin effect. Valley Medical Weight Loss also prescribes phentermine, a sympathomimetic amine that suppresses appetite through central nervous system stimulation, often used in combination protocols or as an alternative for patients with contraindications to GLP-1 therapies. The practice provides lipotropic injections containing methionine, inositol, and choline compounds, along with vitamin B12 supplementation to support energy metabolism during caloric restriction. Treatment protocols are individualized based on patient history, current medications, BMI, and metabolic panel results obtained through initial laboratory assessment.

Dr. Ebrahim Jatta oversees clinical operations and treatment planning, working alongside medical assistants and nursing staff who handle patient intake, injection administration, and follow-up monitoring. The practice model emphasizes efficiency and accessibility, with streamlined appointment scheduling and minimal wait times reported across patient feedback. Medical assistants conduct initial consultations to gather health history, current medication lists, and weight loss goals before physician evaluation. Nurses provide injection technique education for patients transitioning to self-administration and monitor for common side effects including nausea, constipation, and injection site reactions. The clinical team adjusts medication dosing based on tolerance and weight loss velocity, typically following established titration schedules for semaglutide and tirzepatide while monitoring for contraindications.

Patients at Valley Medical Weight Loss typically begin with an in-office consultation that includes vital signs assessment, body composition analysis, and discussion of realistic weight loss timelines based on starting weight and metabolic factors. The practice schedules regular follow-up visits—often weekly or biweekly during initial months—to track progress, adjust medications, and address any adverse effects. Office visits focus on accountability and clinical monitoring rather than extensive nutritional counseling, with the pharmacological interventions serving as the primary weight loss mechanism. Patients receive prescriptions for compounded medications through partner pharmacies, with injection supplies and administration instructions provided during office visits. The practice has developed efficient systems for medication refills and dose adjustments, minimizing administrative delays that can interrupt treatment continuity.

With over 600 patient reviews averaging 4.7 stars, Valley Medical Weight Loss has established a substantial patient base in Phoenix seeking medical weight loss interventions. The practice's multiple Phoenix locations provide geographic accessibility across the metro area, accommodating patients from surrounding communities including Scottsdale, Tempe, and Glendale. The clinic's focus on pharmacotherapy-based weight management distinguishes it from nutrition-only or surgical weight loss programs, serving patients who have not achieved results through diet and exercise alone or who require medical intervention for obesity-related health conditions. The practice does not currently advertise telehealth services, maintaining an in-person model for medication management and clinical monitoring that allows for direct provider-patient interaction and hands-on assessment throughout the weight loss process.